<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
      <journal-title-group>
        <journal-title>BMC Medical Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2350</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26323392</article-id>
      <article-id pub-id-type="pmc">4593198</article-id>
      <article-id pub-id-type="publisher-id">220</article-id>
      <article-id pub-id-type="doi">10.1186/s12881-015-0220-z</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A 5.8&#xA0;Mb interstitial deletion on chromosome Xq21.1 in a boy with intellectual disability, cleft palate, hearing impairment and combined growth hormone deficiency</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Giordano</surname>
            <given-names>M.</given-names>
          </name>
          <address>
            <email>giordano@med.unipmn.it</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Gertosio</surname>
            <given-names>C.</given-names>
          </name>
          <address>
            <email>chiaragerto@live.it</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pagani</surname>
            <given-names>S.</given-names>
          </name>
          <address>
            <email>s.pagani@smatteo.pv.it</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meazza</surname>
            <given-names>C.</given-names>
          </name>
          <address>
            <email>c.meazza@smatteo.pv.it</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fusco</surname>
            <given-names>I.</given-names>
          </name>
          <address>
            <email>ileana.fusco@med.unipmn.it</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bozzola</surname>
            <given-names>E.</given-names>
          </name>
          <address>
            <email>elena.bozzola@opbg.net</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Bozzola</surname>
            <given-names>M.</given-names>
          </name>
          <address>
            <phone>+390382501270</phone>
            <email>mauro.bozzola@unipv.it</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <aff id="Aff1"><label/>Laboratory of Genetics, Department of Health Sciences, University of Eastern Piedmont, Via Solaroli 17, 28100 Novara, Italy </aff>
        <aff id="Aff2"><label/>Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy </aff>
        <aff id="Aff3"><label/>Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy </aff>
        <aff id="Aff4"><label/>Department of Pediatric Medicine, IRCCS Ospedale Pediatrico Bambino Ges&#xF9;, Rome, Italy </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>1</day>
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>1</day>
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>74</elocation-id>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>3</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>8</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Giordano et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Deletions of the long arm of chromosome X in males are a rare cause of X-linked intellectual disability. Here we describe a patient with an interstitial deletion of the Xq21.1 chromosome.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>In a 15&#xA0;year boy, showing intellectual disability, short stature, hearing loss and dysmorphic facial features, a deletion at Xq21.1 was identified by array-CGH. This maternally inherited 5.8&#xA0;Mb rearrangement encompasses 14 genes, including <italic>BRWD3</italic> (involved in X-linked intellectual disability), <italic>TBX22</italic> (a gene whose alterations have been related to the presence of cleft palate), <italic>POU3F4</italic> (mutated in X-linked deafness) and <italic>ITM2A</italic> (a gene involved in cartilage development).</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Correlation between the clinical findings and the function of gene mapping within the deleted region confirms the causative role of this microrearrangement in our patient and provides new insight into a gene possibly involved in short stature.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Xq21.1 deletion</kwd>
        <kwd>Short stature</kwd>
        <kwd>Pituitary hormone deficiency</kwd>
        <kwd>Intellectual disability</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Cytogenetically detectable chromosomal deletions involving chromosome X are rare in males due to the incompatibility with life of nullisomy for large portions of this chromosome. In particular, deletions at Xq21 are poorly described in the literature and only a few cases are reported of male patients with complex phenotypes including neurosensorial deafness, choroideremia, intellectual disability and dysmorphisms [<xref ref-type="bibr" rid="CR1">1</xref>]. About 50 % of the carrier females display almost or completely skewed X inactivation, silencing the abnormal X resulting in a relatively benign phenotype [<xref ref-type="bibr" rid="CR2">2</xref>]. The development of high resolution genomic arrays has made it possible to increase the imbalance detection rate with the identification of cryptic small rearrangements on the X chromosome, some of these containing only a few genes or even just a single gene [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. However, despite the improvement of the analysis resolution, rearrangements at Xq21 are still rarely reported.</p>
      <p>Here we describe a male patient with an interstitial deletion of the Xq21.1 chromosome, determined through array comparative genome hybridization (aCGH). We sought to explain the clinical outcome, according to genotype-phenotype correlation, focusing on the genes possibly involved in the clinical phenotype including intellectual impairment, hearing loss, cleft-palate and short stature.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>The patient was born at the 41st week of gestation by caesarean section due to fetal macrosomia. The birth weight was 4,530&#xA0;g (&gt;97&#xB0; percentile), birth length 54&#xA0;cm (90&#x2013;97&#xB0; percentile), and head circumference 40&#xA0;cm (&gt;97&#xB0; percentile). Apgar scores were 9 and 10 at 1 and 5&#xA0;minutes, respectively. The propositus was the only child of non-consanguineous Italian parents. The father was 36 and the mother was 28&#xA0;years old. At birth, the patient showed cleft palate (plastic surgery of the hard palate was performed at the 5th month of life), hip dysplasia (corrected with retractor), right blepharoptosis (surgically corrected at 7&#xA0;years of age) and dysmorphic face. At the fourth month of age, the parents noted the presence of severe head and limb hypotonia and a delayed psychomotor development. At 18&#xA0;months, bilateral sensorineural hearing loss was diagnosed and a bilateral hearing aid was implanted.</p>
      <p>The standard cytogenetic analysis revealed a normal male karyotype (46,XY). The patient proved negative for chromosome 22.11.2 deletion syndrome and fragile-X syndrome analysis. The family history was negative for intellectual disability.</p>
      <p>Neurological examinations were performed, including a brain MRI at the age of 1&#xA0;year with evidence of perinatal outcome suffering of the white matter, thinning of the corpus callosum and mild ventricular asymmetry. At 8&#xA0;years of age, the brain MRI was repeated and showed the presence of mild ectasia of the perivascular spaces, soft signal hyperintensity of the periventricular white matter in the occipital region bilaterally as incomplete myelination.</p>
      <p>At 3&#xA0;years of age, because of short stature, a growth hormone (GH) stimulation test with arginine (GH peak: 5&#xA0;ng/ml; n.v.&#x2009;&gt;&#x2009;10&#xA0;ng/ml) and with glucagon (GH peak: 2.1&#xA0;ng/ml; n.v.&#x2009;&gt;&#x2009;10&#xA0;ng/ml) were performed and led to a diagnosis of complete growth hormone deficiency (GHD). GH replacement therapy was therefore started at the age of 4&#xA0;years and stopped at the age of 9&#xA0;years, for poor growth response. The patient did not return for further medical examination until the age of 15&#xA0;years, when he was reassessed at our center for growth arrest associated with suspected hypogonadism (gonadal volume 2&#xA0;cc bilaterally). His height was 151&#xA0;cm (&#x2212;2.23 SDS), BMI 26.97&#xA0;kg/m<sup>2</sup> (1.47 SDS). The gonadotropin evaluation tests performed with luteinizing-hormone-releasing hormone (LHRH) revealed deficit of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) with a LH peak of 4.1&#xA0;mU/ml (prepubertal value) and FSH peak of 7.3&#xA0;mU/ml (prepubertal value). The stimulation test with growth-hormone-releasing hormone (GHRH) and arginine confirmed the severe GHD (GH peak: 0.1&#xA0;ng/ml; n.v.&#x2009;&gt;&#x2009;19&#xA0;ng/ml). Insulin-like growth factor (IGF-1) was below the normal range (&lt;25.0&#xA0;ng/ml; &#x2212;7.81 SDS). Adrenal, thyroid, liver and kidney function showed normal range values. The ECG and the cardiological examination were normal. A delayed bone age of 2&#xA0;years compared with chronological age was detected. A pituitary MRI was also performed and showed a normal morphology of the adenohypophysis, smaller than normal for the age without significant alterations in signal intensity before, during and after the administration of contrast medium. The patient therefore restarted GH replacement therapy.</p>
      <p>For the psychomotor retardation with hyperactivity, the child attends psychomotor and speech therapy regularly and he is currently being treated with Levomepromazine (75&#xA0;mg/day) and Promazine (50 gtt/day). The boy has a poor ability to tolerate frustration and there have been some episodes of verbal aggression against its peers. A neuropsychiatric test (Wisc IV test) showed an intellectual disability with an IQ&#x2009;&lt;&#x2009;70.</p>
      <p>Concerning the morphological aspect (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>), the patient presents gynoid habitus, abdominal fat, pseudogynecomastia (presence of only adipose tissue), hypoplastic genitalia with microtestes (volume of 2&#xA0;ml), generalized hypotonia, genus valgus, pes planus, short toes, caf&#xE9; au lait spot on the left shoulder and in the right lumbar region. Facial features (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>) are characterized by: macrocephaly, broad forehead, prominent nose root and coarse nasal pyramid, anteverted nares, white tuft of hair on the top of his head (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Morphological appearance of the patient at 15&#xA0;years of age. Gynoid habitus, abdominal fat, pseudogynecomastia (presence of only adipose tissue), hypoplastic genitalia with microtestes (volume of 2&#xA0;ml), generalized hypotonia, genus valgus, pes planus, short toes</p></caption><graphic xlink:href="12881_2015_220_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Facial features of the patient. Patient showing facial characteristics, including macrocephaly, broad forehead, prominent nose root and coarse nasal pyramid, anteverted nares, short palpebral fissures, large and prominent ears</p></caption><graphic xlink:href="12881_2015_220_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>White tuft of hair on the top of the head</p></caption><graphic xlink:href="12881_2015_220_Fig3_HTML" id="MO3"/></fig></p>
      <p>The mother of the boy presents some atypical characteristics, such as coarse facial features, prominent frontal bossing, big hands and progressive hearing impairment. She showed normal height and good intellectual development.</p>
    </sec>
    <sec id="Sec3" sec-type="materials|methods">
      <title>Material and Methods</title>
      <sec id="Sec4">
        <title>Array CGH</title>
        <p>DNA was extracted from whole blood of the patient by standard procedures. Array Comparative Genomic Hybridization (array-CGH) was performed using the Cytochip ISCA 4x180K (BlueGnome) containing 181,873 oligonucleotide probes (BlueGnome Ldt, Cambridge, UK) with a mean resolution of 16.30 Kb (25 Kb resolution on the backbone, 3.4 Kb resolution on genes). The CytoChip ISCA arrays are designed to investigate constitutional disorders through a combination of increased probe density in regions or genes associated with known constitutional disorders and regular spacing of probes on the genomic backbone, with no known disease association. Data analysis was performed using InnoScan 710 Microarray Scanner (Innopsys Inc. Chicago IL, USA) and Bluefuse software (BlueGnome Ldt, Cambridge, UK). Copy number variations (CNVs) reported in the Database of Genomic Variants <ext-link ext-link-type="uri" xlink:href="http://projects.tcag.ca/variation/and">http://projects.tcag.ca/variation/and</ext-link> in in-house databases of benign CNVs were excluded from further analysis. Genomic positions refer to the Human Genome February 2009 assembly (GRCh37/hg19).</p>
      </sec>
      <sec id="Sec5">
        <title>Sequencing</title>
        <p>The <italic>PROP1</italic> and <italic>GJB2</italic> genes were screened for the presence of causative mutations by direct sequencing. Briefly genomic DNA was amplified by polymerase chain reaction (PCR) using primers designed to specifically amplify the coding regions and the intron/exon boundaries of each gene. PCR conditions and primer sequences are available upon request. The PCR products were visualized on a 2&#xA0;% agarose gel and purified using ExoSAP-IT enzymatic PCR clean up system (Affimetrix, Santa Clara, CA). The purified products were then sequenced with the Big Dye Terminator kit (Applied Biosystems, Foster City, CA) and the automatic sequencer ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA).</p>
      </sec>
      <sec id="Sec6">
        <title>Database search</title>
        <p>We performed a search in DECIPHER database (<ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/">https://decipher.sanger.ac.uk/</ext-link>) and ISCA (<ext-link ext-link-type="uri" xlink:href="https://iscaconsortium.org/">https://iscaconsortium.org/</ext-link>) in order to identify cases of patients carrying similar deletions.</p>
      </sec>
    </sec>
    <sec id="Sec7" sec-type="results">
      <title>Results</title>
      <p>At the age of 18&#xA0;months, the patient was tested for the presence of causative mutations in the gene encoding connexin 26 (<italic>GJB2</italic>), as he manifested bilateral neurosensorial hearing loss. No mutation associated with hearing impairment was identified in this gene.</p>
      <p>The array-CGH analysis, performed at the age of 13&#xA0;years, revealed the presence of an interstitial deletion at Xq21.1 (77.456.818x1,77.489.632-83.255.802x0,83.287.869x1), of approximately 5.8&#xA0;Mb (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>). The same deletion was present at the heterozygous state in the mother.<fig id="Fig4"><label>Fig. 4</label><caption><p>Xq21.1 Deletion. <bold>a</bold> Graphic representation of part of Xq (corresponding to the region included in the dotted box) with protein coding genes included in this region. The deletion at Xq21.1 detected in our patient (ChrX:77.456.818x1,77.489.632-83.255.802x0,83.287.869x1) is represented by a red rectangle above the boxed region. <bold>b</bold> Schematic representation of the Xq21.1 deleted region (<italic>in red</italic>) in our patient and other deletions reported in the Decipher and ISCA database in male patients (<italic>in black</italic>) and female patients (<italic>in grey</italic>). The ID of each patient is reported. The clinical features of the patients are reported in parentheses below the corresponding deletion as described in Decipher (<ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/">https://decipher.sanger.ac.uk/</ext-link>) and ISCA (<ext-link ext-link-type="uri" xlink:href="https://iscaconsortium.org/">https://iscaconsortium.org/</ext-link>)</p></caption><graphic xlink:href="12881_2015_220_Fig4_HTML" id="MO4"/></fig></p>
      <p>A paternal inherited deletion on chromosome 22q11.2 of about 105&#xA0;kb (18.894.864x2, 18.905.139-19.010.478x1, 1.190.35352x2) was also identified, included within the 3&#xA0;Mb deletion of the DiGeorge syndrome. However, it is likely a benign CNV as it is present in the Database of Genomic Variants (<ext-link ext-link-type="uri" xlink:href="http://dgv.tcag.ca/dgv">http://dgv.tcag.ca/dgv</ext-link>).</p>
      <p>The Xq21.1 deleted region was examined using the Human resource websites (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/genome/guide/human">http://www.ncbi.nlm.nih.gov/projects/genome/guide/human</ext-link>) at NCBI and the Archive EnsEMBL (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/info/website/archives/index">http://www.ensembl.org/info/website/archives/index</ext-link>). This region contains 14 genes, some of them with a known function (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Among these, three genes (<italic>TBX22, BRW3</italic> and <italic>POU3F4</italic>) have been previously reported mutated in well defined disorders, thus facilitating the phenotype-genotype correlation in our patient (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). However, none of the genes included in the deletion have been previously correlated to the pituitary hormone deficiencies observed in our patient. The <italic>PROP1</italic> gene was thus sequenced in order to detect a gene defect elsewhere that could explain the GH and gonadotropin deficiency, but no mutation was identified.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Protein encoding genes with a known function included in the Xq21.1 deletion</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th>Protein</th><th>Protein function</th><th>Disease</th></tr></thead><tbody><tr><td>
<italic>CYSLTR1</italic>
</td><td>Cysteinyl leukotriene receptor 1</td><td>Mediation of bronchoconstriction via activation of a phosphatidylinositol-calcium second messenger system</td><td>None</td></tr><tr><td>
<italic>ZCCHC5</italic>
</td><td>Zinc finger, CCHC domain containing 5</td><td>Member of a family of gag-related retrotransposon genes</td><td>None</td></tr><tr><td>
<italic>LPAR4</italic>
</td><td>Lysophosphatidic acid receptor 4</td><td>Monocytic differentiation</td><td>None</td></tr><tr><td>
<italic>P2RY10</italic>
</td><td>Purinergic receptor P2Y, G-protein coupled, 10</td><td>Stimulation of diacylglyceride-dependent protein kinases</td><td>None</td></tr><tr><td>
<italic>GPR174</italic>
</td><td>G protein-coupled receptor 174</td><td>Lysophosphatidylserine receptor involved in intracellular cAMP increase</td><td>None</td></tr><tr><td>
<italic>ITM2A</italic>
</td><td>Integral membrane protein 2A</td><td>Chondrogenesis</td><td>None</td></tr><tr><td>
<italic>TBX22</italic>
</td><td>T-box 22</td><td>Palatogenesis</td><td>Cleft palate with ankyloglossia</td></tr><tr><td>
<italic>BRWD3</italic>
</td><td>Bromodomain and WD repeat domain containing 3</td><td>Chromatin-modification</td><td>Intellectual disability X-linked with macrocephaly</td></tr><tr><td>
<italic>HMGN5</italic>
</td><td>High mobility group nucleosome binding domain 5</td><td>Nucleosomal binding and transcriptional activation</td><td>None</td></tr><tr><td>
<italic>SH3BGRL</italic>
</td><td>SH3 domain binding glutamate-rich protein like</td><td>Signal transduction</td><td>None</td></tr><tr><td>
<italic>POU3F4</italic>
</td><td>POU class 3 homeobox 4</td><td>Inner ear development</td><td>Non-syndromic hearing loss</td></tr><tr><td>
<italic>CYLC1</italic>
</td><td>Cylicin, basic protein of sperm head cytoskeleton 1</td><td>Spermatid differentiation</td><td>None</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec8" sec-type="discussion">
      <title>Discussion</title>
      <p>We report a maternally inherited deletion of approximately 5.8&#xA0;Mb at Xq21.1, in a male subject with developmental delay, dysmorphic facial features, cleft palate, intellectual disability, short stature and hearing loss. The deleted region includes 14 OMIM genes: <italic>CYSLTR1, ZCCHC5, LPAR4, P2RY10, GPR174, ITM2A, TBX22, BRWD3, HMGN5, SH3BGRL, HMGN5, SH3BGRL, POU3F4, CYLC1</italic> (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref> and Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>)<italic>.</italic> Among these, <italic>TBX22, BRWD3</italic> and <italic>POU3F4</italic> well explain some of the clinical features of this patient.</p>
      <p>Mutations in the <italic>TBX22</italic> gene are a well established cause of X-linked cleft palate with ankyloglossia as well as contributing to the prevalence of isolated cleft palate [<xref ref-type="bibr" rid="CR5">5</xref>]. More rarely, other craniofacial anomalies including cleft lip and hypodontia have also been related to <italic>TBX22</italic> variants [<xref ref-type="bibr" rid="CR6">6</xref>]. The phenotypic spectrum of subjects bearing <italic>TBX22</italic> mutations can vary, even within the same family, from asymptomatic females to males or females with a bifid uvula, a cleft of the soft palate, or a complete cleft of the hard and soft secondary palate, along with ankyloglossia [<xref ref-type="bibr" rid="CR7">7</xref>].</p>
      <p>Genetic hearing loss has an extremely varied etiology, with a plethora of genes involved in the autosomal and X-linked forms with overlapping phenotypes [<xref ref-type="bibr" rid="CR8">8</xref>]. Among the main genetic defects, mutations within connexin 26 (<italic>GJB2</italic>) and connexin 30 (<italic>GJB6</italic>) are usually associated with severe to profound sensorineural deafness. Our patient had been screened for the presence of mutations in <italic>GJB2</italic> before performing array-CGH, and was negative. The deafness causative gene is undoubtedly <italic>POU3F4,</italic> which causes the X-linked neurosensorial deafness <italic>DFN3</italic>. This defect is associated with either <italic>POU3F4</italic> point mutations or small deletions in a region located at 900 Kb upstream of the gene and disturbing a regulatory element [<xref ref-type="bibr" rid="CR9">9</xref>]. Male patients show a well characterized phenotype with both stapes fixation and progressive mixed hearing loss [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Hearing loss was also observed in the mother of our patient as well as in about 40&#xA0;% of the <italic>POU3F4</italic> mutation carrier females. Carrier females usually exhibit a postlingual onset of the hearing impairment that progresses over time [<xref ref-type="bibr" rid="CR12">12</xref>] with a variable expressivity attributable to variations in the degree of skewing of X inactivation.</p>
      <p>Loss of function mutations affecting <italic>BRWD3</italic> are associated with a phenotype including mild to moderate intellectual disability, macrocephaly, dysmorphic facial features, skeletal signs and behavioral disturbance [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Among these alterations, a partial deletion encompassing 74 Kb and including the 30 last exons of the <italic>BRWD3</italic> gene was reported in a male with high forehead, deep-set eyes, hypertelorism, short palpebral fissures, anteverted nares, downturned corners of the mouth, pointed chin, and skeletal anomalies. This phenotype is similar to that of the patient presented here: macrocephaly, dysmorphic facial features including prominent forehead and abnormal ears, behavioral disturbance, skeletal symptoms like pes planus, and cubitus valgus. These findings strongly suggest that the lack of <italic>BRWD3</italic> causes intellectual disability, macrocephaly and possibly the skeletal symptoms (pes planus and cubitus valgus) observed in our patient. It has been demonstrated that BRWD3 plays a crucial role in ubiquitination, as part of the ubiquitin/proteasome system. In Drosophila, BRWD3 belongs to the CUL4-ROC1-DDB1 E3 ligase complex in which it acts as a CULLIN (CUL)4-associated factor that mediates light-dependent binding of CRY (Cryptochrome, a circadian photoreceptor) to the complex, inducing the ubiquitination of dCRY and its light-induced degradation [<xref ref-type="bibr" rid="CR15">15</xref>]. The ubiquitin-proteasome system plays a crucial role in brain development and is a critical regulator of the synaptic plasticity and long-term memory formation [<xref ref-type="bibr" rid="CR16">16</xref>]. Intriguingly, in humans mutations of the CUL4B, which encode a ubiquitin 3 ligase subunit cause an X-linked syndrome characterized by intellectual impairment, macrocephaly, central obesity, hypogonadism, pes cavus and tremor [<xref ref-type="bibr" rid="CR17">17</xref>], a phenotype that largely overlaps with that observed in patients carrying BRWD3 mutations/deletions, including the present case. As both BRWD3 and CUL4B are part of the same complex it is likely that alterations of BRWD3 influence the ubiquitin-proteasome system similarly to other intellectual disability syndromes, whose prototype is represented by the Angelman Syndrome which is caused by mutations of the ubiquitin ligase-encoding UBE3A gene (MIM 105830).</p>
      <p>The search in the Decipher and ISCA databases for similar size deletions at Xq21.1 led to the identification of six deletions in males with syndromic intellectual disability and developmental delay (DECIPHER 287069,253735, 257570,292180 and ISCA nsv533989, nsv530231, Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>) and in one patient with no further phenotype details (DECIPHER 283100, Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>) but none of these exactly corresponds to that of our patient. However, among those observed in female patients, there are two deletions (DECIPHER 262726 and 265126, Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>) that completely cover that of our patient. The milder associated phenotype includes broad nasal tip, skeletal defects, speech delay, and cleft palate, which are also features of the present patient.</p>
      <p>Other remarkable clinical signs of our patient are short stature and multiple pituitary hormone deficiency. The presence of mutations in <italic>PROP1</italic>, the most common genetic cause of combined pituitary hormone deficiency (CPHD) associated with short stature [<xref ref-type="bibr" rid="CR18">18</xref>], was excluded. It is interesting that the deletion partially overlaps with regions duplicated in patients with multiple congenital anomalies, developmental delay, GH deficiency and short stature [<xref ref-type="bibr" rid="CR19">19</xref>&#x2013;<xref ref-type="bibr" rid="CR21">21</xref>]. This suggests that Xq21.1 might contain either a protein coding gene or a regulatory element involved in pituitary hormone secretion. Within the 5.8&#xA0;Mb region there is no evidence for a protein coding gene directly involved in pituitary functioning. However, <italic>ITM2A</italic>, included in the deletion, might be related to the severe short stature as it encodes an integral transmembrane protein involved in early cartilage development [<xref ref-type="bibr" rid="CR22">22</xref>]. It has been suggested that the expression of <italic>ITM2A</italic> influences the chondrogenic differentiation potential of mesenchymal stem cells in vitro [<xref ref-type="bibr" rid="CR23">23</xref>]. It might be hypothesized that the absence of ITM2A greatly influences the cartilage development with a possible impact on postnatal growth.</p>
    </sec>
    <sec id="Sec9" sec-type="conclusions">
      <title>Conclusions</title>
      <p>In conclusion, a detailed comparison of the clinical characteristics and the function of the genes included in the Xq21.1 delete region confirm the causative role of this rearrangement in our patient. Moreover, the presence of a gene involved in cartilage differentiation suggests that <italic>ITM2A</italic> might be responsible for growth impairment.</p>
    </sec>
    <sec id="Sec10">
      <title>Consent</title>
      <p>Written informed consent was obtained from the mother of the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>array-CGH</term>
          <def>
            <p>Array comparative genomic hybridization</p>
          </def>
        </def-item>
        <def-item>
          <term>XLID</term>
          <def>
            <p>X-linked Intellectual disability</p>
          </def>
        </def-item>
        <def-item>
          <term>GHD</term>
          <def>
            <p>Growth hormone deficiency</p>
          </def>
        </def-item>
        <def-item>
          <term>MRI</term>
          <def>
            <p>Magnetic resonance imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>IQ</term>
          <def>
            <p>Intelligence quotient</p>
          </def>
        </def-item>
        <def-item>
          <term>GH</term>
          <def>
            <p>Growth hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>LHRH</term>
          <def>
            <p>Luteinizing-hormone-releasing hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>LH</term>
          <def>
            <p>Luteinizing hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>FSH</term>
          <def>
            <p>Follicle-stimulating hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>GHRH</term>
          <def>
            <p>Growth-hormone-releasing hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>IGF-1</term>
          <def>
            <p>Insulin-like growth factor</p>
          </def>
        </def-item>
        <def-item>
          <term>SDS</term>
          <def>
            <p>Standard deviation score</p>
          </def>
        </def-item>
        <def-item>
          <term>ECG</term>
          <def>
            <p>Electrocardiography</p>
          </def>
        </def-item>
        <def-item>
          <term>CNVs</term>
          <def>
            <p>Copy number variations</p>
          </def>
        </def-item>
        <def-item>
          <term>PCR</term>
          <def>
            <p>Polymerase chain reaction</p>
          </def>
        </def-item>
        <def-item>
          <term>CPHD</term>
          <def>
            <p>Combined pituitary hormone deficiency</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>M. Giordano and C. Gertosio contributed equally to this work.</p>
      </fn>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The author(s) declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>GM and GC made substantial contributions to acquisition, analysis and interpretation of data; they were also involved in drafting the manuscript; FI played a role in molecular diagnosis; PS, MC, and BE organized the clinical data for the manuscript, contributed to revision and interpretation of genetic studies; BM made substantial contributions to conception and design, revised the manuscript critically for important intellectual content. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgement</title>
      <p>The authors are grateful to Susan West for English revision of the paper.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cremers</surname>
              <given-names>FP</given-names>
            </name>
            <name>
              <surname>Sankila</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Brunsmann</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Jay</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jay</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pinckers</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>van de Pol</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>de la Chapelle</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pawlowitzki</surname>
              <given-names>IH</given-names>
            </name>
            <name>
              <surname>Ropers</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>Deletions in patients with classical choroideremia vary in size from 45&#xA0;kb to several megabases</article-title>
          <source>Am J Hum Genet.</source>
          <year>1990</year>
          <volume>47</volume>
          <fpage>622</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">2220804</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Plenge</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Lubs</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Willard</surname>
              <given-names>HF</given-names>
            </name>
          </person-group>
          <article-title>Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders</article-title>
          <source>Am J Hum Genet.</source>
          <year>2002</year>
          <volume>71</volume>
          <fpage>168</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="doi">10.1086/341123</pub-id>
          <pub-id pub-id-type="pmid">12068376</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lugtenberg</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Veltman</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>van Bokhoven</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>High-resolution genomic microarrays for X-linked mental retardation</article-title>
          <source>Genet Med.</source>
          <year>2007</year>
          <volume>9</volume>
          <fpage>560</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1097/GIM.0b013e318149e647</pub-id>
          <pub-id pub-id-type="pmid">17873643</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Isrie</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Foryen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Devirendt</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>de Ravel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fryns</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Vermeesch</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Van Esch</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Sporadic patients with intellectual disability: Contribution of X-chromosome copy number variants</article-title>
          <source>Eur J Med Genet.</source>
          <year>2012</year>
          <volume>55</volume>
          <fpage>577</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmg.2012.05.005</pub-id>
          <pub-id pub-id-type="pmid">22659343</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andreou</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Pauws</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Bussen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Doudney</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Kispert</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brosens</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Stanier</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>TBX22 missense mutations found in patients with X-linked cleft palate affect DNA binding, sumoylation, and transcriptional repression</article-title>
          <source>Am J Hum Genet.</source>
          <year>2007</year>
          <volume>81</volume>
          <fpage>700</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="doi">10.1086/521033</pub-id>
          <pub-id pub-id-type="pmid">17846996</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaewkhampa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jotikasthira</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Malaivijitnond</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kantaputra</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>TBX22 mutation associated with cleft lip/palate, hypodontia, and limb anomaly</article-title>
          <source>Cleft Palate Craniofac J.</source>
          <year>2012</year>
          <volume>49</volume>
          <fpage>240</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1597/10-208</pub-id>
          <pub-id pub-id-type="pmid">21375406</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pauws</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Peskett</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Boissin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hoshino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mengrelis</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Carta</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Abruzzo</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Lees</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Erickson</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Stanier</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>X-linked CHARGE-Like Abruzzo-Erickson syndrome and classic cleft palate with ankyloglossia result from TBX22 splicing mutations</article-title>
          <source>Clin Genet.</source>
          <year>2013</year>
          <volume>83</volume>
          <fpage>352</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1399-0004.2012.01930.x</pub-id>
          <pub-id pub-id-type="pmid">22784330</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raviv</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dror</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Avraham</surname>
              <given-names>KB</given-names>
            </name>
          </person-group>
          <article-title>Hearing loss: a common disorder caused by many rare alleles</article-title>
          <source>Ann N Y Acad Sci.</source>
          <year>2010</year>
          <volume>1214</volume>
          <fpage>168</fpage>
          <lpage>79</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1749-6632.2010.05868.x</pub-id>
          <pub-id pub-id-type="pmid">21175685</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Kok</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Vossenaar</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Cremers</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Dahl</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Laporte</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Lacombe</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fischel-Ghodsian</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Parnes</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Thorpe</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bitner-Glindzicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pander</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Heilbronner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Graveline</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>den Dunnen</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Brunner</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Ropers</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Cremers</surname>
              <given-names>FP</given-names>
            </name>
          </person-group>
          <article-title>Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900&#xA0;kb proximal to the DFN3 gene POU3F4</article-title>
          <source>Hum Mol Genet.</source>
          <year>1996</year>
          <volume>5</volume>
          <fpage>1229</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/5.9.1229</pub-id>
          <pub-id pub-id-type="pmid">8872461</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rush</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Schaefer</surname>
              <given-names>GB</given-names>
            </name>
          </person-group>
          <article-title>Identification of an X-linked deletion syndrome through comparative genomic hybridization microarray</article-title>
          <source>Semin Pediatr Neurol.</source>
          <year>2010</year>
          <volume>17</volume>
          <fpage>51</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1016/j.spen.2010.02.008</pub-id>
          <pub-id pub-id-type="pmid">20434696</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vore</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Hoppe</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Forrester</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Deletion of and novel missense mutation in POU3F4 in 2 families segregating X-linked nonsyndromic deafness</article-title>
          <source>Arch Otolaryngol Head Neck Surg.</source>
          <year>2005</year>
          <volume>131</volume>
          <fpage>1057</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1001/archotol.131.12.1057</pub-id>
          <pub-id pub-id-type="pmid">16365218</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marlin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Moizard</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>David</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chaissang</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Raynaud</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jonard</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Feldmann</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Loundon</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Denoyelle</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Toutain</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Phenotype and genotype in females with POU3F4 mutations</article-title>
          <source>Clin Genet.</source>
          <year>2009</year>
          <volume>76</volume>
          <fpage>558</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1399-0004.2009.01215.x</pub-id>
          <pub-id pub-id-type="pmid">19930154</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Field</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tarpey</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Edkins</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>O'Meara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tofts</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Teague</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dicks</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Barthorpe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Buck</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Halliday</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hills</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jenkinson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Menzies</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mironenko</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Raine</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shepherd</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Small</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Varian</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Widaa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mallya</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Wooster</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Friend</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Corbett</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Partington</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mulley</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bobrow</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gecz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Stratton</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Futreal</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Raymond</surname>
              <given-names>FL</given-names>
            </name>
          </person-group>
          <article-title>Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly</article-title>
          <source>Am J Hum Genet.</source>
          <year>2007</year>
          <volume>81</volume>
          <fpage>367</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="doi">10.1086/520677</pub-id>
          <pub-id pub-id-type="pmid">17668385</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grotto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Drouin-Garraud</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ounap</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Puusepp-Benazzouz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schuurs-Hoeijmakers</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Le Meur</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Chambon</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fehrenbach</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>van Bokhoven</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fr&#xE9;bourg</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>de Brouwer</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Saugier-Veber</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Clinical assessment of five patients with BRWD3 mutation ad Xq21.1 gives further evidence for mild to moderate intellectual disability and macrocephaly</article-title>
          <source>Eur J Med Genet</source>
          <year>2014</year>
          <volume>57</volume>
          <fpage>200</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmg.2013.12.012</pub-id>
          <pub-id pub-id-type="pmid">24462886</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozturk</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>VanVickle-Chavez</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Akileswaran</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Van Gelder</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Sancar</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Ramshackle (Brwd3) promotes light-induced ubiquitylation of Drosophila Cryptochrome by DDB1-CUL4-ROC1 E3 ligase complex</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2013</year>
          <volume>110</volume>
          <fpage>4980</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1303234110</pub-id>
          <pub-id pub-id-type="pmid">23479607</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jarome</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Kwapis</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Hallengren</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Helmstetter</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>The ubiquitin-specific protease 14 (USP14) is a critical regulator of long-term memory formation</article-title>
          <source>Learn Mem.</source>
          <year>2013</year>
          <volume>21</volume>
          <fpage>9</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1101/lm.032771.113</pub-id>
          <pub-id pub-id-type="pmid">24344179</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tarpey</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Raymond</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>O'Meara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Edkins</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Teague</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dicks</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tofts</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Avis</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Barthorpe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Buck</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Halliday</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hills</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jenkinson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Menzies</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mironenko</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Raine</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shepherd</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Small</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Varian</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Widaa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mallya</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Holder</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Smithson</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Hurst</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Clayton-Smith</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kerr</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Boyle</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vandeleur</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rodriguez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Slaugh</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Easton</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Wooster</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bobrow</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gecz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Futreal</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Stratton</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Partington</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor</article-title>
          <source>Am J Hum Genet</source>
          <year>2007</year>
          <volume>80</volume>
          <fpage>345</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="doi">10.1086/511134</pub-id>
          <pub-id pub-id-type="pmid">17236139</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pf&#xE4;ffle</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Klammt</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency</article-title>
          <source>Best Pract Res Clin Endocrinol Metab.</source>
          <year>2011</year>
          <volume>25</volume>
          <fpage>43</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1016/j.beem.2010.10.014</pub-id>
          <pub-id pub-id-type="pmid">21396574</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yokoyama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Narahara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tsuji</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Moriwake</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kanzaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Murakami</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Namba</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ninomiya</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Higuchi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Seino</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Growth hormone deficiency and empty sella syndrome in a boy with dup(X)(q13.3-q21.2)</article-title>
          <source>Am J Med Genet</source>
          <year>1992</year>
          <volume>42</volume>
          <fpage>660</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1002/ajmg.1320420506</pub-id>
          <pub-id pub-id-type="pmid">1632433</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shapira</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dar</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bar-El</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bar-Nitzan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Even</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Borochowitz</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Inherited inverted duplication of X chromosome in a male: report of a patient and review of the literature</article-title>
          <source>Am J Med Genet.</source>
          <year>1997</year>
          <volume>72</volume>
          <fpage>409</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19971112)72:4&lt;409::AID-AJMG7&gt;3.0.CO;2-L</pub-id>
          <pub-id pub-id-type="pmid">9375722</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sismani</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Donoghue</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Alexandrou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Karkaletsi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Christopoulou</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Konstantinidou</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Livanos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Patsalis</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Velissariou</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>A prenatally ascertained, maternally inherited 14.8&#xA0;Mb duplication of chromosomal bands Xp13.23-q21.31 associated with multiple congenital abnormalities in a male fetus</article-title>
          <source>Gene</source>
          <year>2013</year>
          <volume>530</volume>
          <fpage>138</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="doi">10.1016/j.gene.2013.08.032</pub-id>
          <pub-id pub-id-type="pmid">23973723</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van den Plas</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Merregaert</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>In vitro studies on Itm2a reveal its involvement in early stages of the chondrogenic differentiation pathway</article-title>
          <source>Biol Cell.</source>
          <year>2004</year>
          <volume>96</volume>
          <fpage>463</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biolcel.2004.04.007</pub-id>
          <pub-id pub-id-type="pmid">15325075</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boeuf</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>B&#xF6;rger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hennig</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Winter</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kasten</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Richter</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Enhanced ITM2A expression inhibits chondrogenic differentiation of mesenchymal stem cells</article-title>
          <source>Differentiation.</source>
          <year>2009</year>
          <volume>78</volume>
          <fpage>108</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="doi">10.1016/j.diff.2009.05.007</pub-id>
          <pub-id pub-id-type="pmid">19541402</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
